Joseph Truitt is CEO at ACHILLION PHARMACEUTICALS INC (ACHN). They have made 3 open-market trades across 2 companies since 2014, most recently 2023-05-17.
CIK 0001452429
2 open-market purchases totalling $24K since 2016, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LRMR | BUY | 2023-05-17 | 2023-05-18 | $3.73 | $10K | -4.7% | -10.1% | +3.6% |
| ACHN | SELL | 2019-10-16 | 2019-10-18 | $6.37 | $1.7M | +4.9% | +2.6% | +2.3% |
| ACHN | BUY | 2016-12-02 | 2016-12-05 | $4.06 | $14K | -4.8% | +0.0% | -7.0% |
| ACHN | SELL · 10b5-1 | 2014-08-25 | 2014-08-26 | $10.82 | $271K | -25.7% | -1.9% | -1.9% |
| ACHN | SELL · 10b5-1 | 2014-06-16 | 2014-06-17 | $7.82 | $196K | -25.7% | -1.9% | -1.9% |
| ACHN | SELL · 10b5-1 | 2014-06-09 | 2014-06-11 | $6.02 | $301K | -25.7% | -1.9% | -1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.